Description Usage Arguments Value References Examples
This function calculates the promising zone boundaries at an interim analysis of a 
clinical trial
| 1 2 3 4 5 6 7 8 9 10 11 12 13 | 
| r | Proportion of subjects assigned to active group | 
| n1 | Number of patients / events at first interim analysis (NULL if parameter f provided) | 
| n2 | Number of patients / events at final analysis | 
| alpha_1s | one-sided alpha | 
| eff_null | effect corresponding with null hypothesis (e.g. 1 for hazard rates, 0 for difference)  | 
| SE | standard error: has to be provided if type not equal to "HR". If for instance SE =1  | 
| type | if type="HR", then SE is calculated, if type="general", then SE's have to be provided  | 
| pow | Power, needed to calculate sample size in second part provided to obtain given power | 
| f | n1/n2 at interim analysis. Only to be provided if n1 and n2 not provided | 
| max | (Maximum sample size)/(original sample size), could be for instance 1.5, 2 or 3 | 
| plot_effect | TRUE if plotting boundaries with corresponding effect scale | 
a list of three vectors
CP_ll lower boundary of promising zone (z-score, b-value, conditional power, effect scale)
CP_ul upper boundary of promising zone (z-score, b-value, conditional power, effect scale)
Lan and Wittes. The B-Value: A Tool for Monitoring Data. Biometrics 1988;44:579-585 
Mehta CR, Pocock SJ. Adaptive increase in sample size when interim results are promising: A practical 
guide with examples. Statist. Med. 2011;30:3267–3284
| 1 2 | 
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.